Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (2) , 144-147
- https://doi.org/10.1016/s0002-9149(98)00323-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Probucol and Multivitamins in the Prevention of Restenosis after Coronary AngioplastyNew England Journal of Medicine, 1997
- Use of Cilostazol, a Novel Antiplatelet Agent, in a Post-Palmaz-Schatz Stenting RegimenThe American Journal of Cardiology, 1997
- Effect of Cilostazol in Preventing Restenosis After Percutaneous Transluminal Coronary AngioplastyThe American Journal of Cardiology, 1997
- Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1996
- CilostazolCardiovascular Drug Reviews, 1993
- Effect of Cilostazol, a Cyclic AMP Phosphodiesterase Inhibitor, on the Proliferation of Rat Aortic Smooth Muscle Cells in CultureJournal of Cardiovascular Pharmacology, 1992